News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shire Pharmaceuticals (SHPGY)'s Gaucher Medicine Vpriv Gets EU Agency OK



6/25/2010 7:11:49 AM

LONDON, June 25 (Reuters) - The European Medicines Agency recommended approval of Shire's (SHP.L) Vpriv drug on Friday to treat Gaucher disease, following an accelerated approval process.

Read at Wall Street Journal
Read at Nasdaq
Read at Reuters


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES